» Articles » PMID: 37507005

Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes

Abstract

Background: Race-specific spirometry reference equations are used globally to interpret lung function for clinical, research, and occupational purposes, but inclusion of race is under scrutiny.

Research Question: Does including self-identified race in spirometry reference equation formation improve the ability of predicted FEV values to explain quantitative chest CT abnormalities, dyspnea, or Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification?

Study Design And Methods: Using data from healthy adults who have never smoked in both the National Health and Nutrition Survey (2007-2012) and COPDGene study cohorts, race-neutral, race-free, and race-specific prediction equations were generated for FEV Using sensitivity/specificity, multivariable logistic regression, and random forest models, these equations were applied in a cross-sectional analysis to populations of individuals who currently smoke and individuals who formerly smoked to determine how they affected GOLD classification and the fit of models predicting quantitative chest CT phenotypes or dyspnea.

Results: Race-specific equations showed no advantage relative to race-neutral or race-free equations in models of quantitative chest CT phenotypes or dyspnea. Race-neutral reference equations reclassified up to 19% of Black participants into more severe GOLD classes, while race-neutral/race-free equations may improve model fit for dyspnea symptoms relative to race-specific equations.

Interpretation: Race-specific equations offered no advantage over race-neutral/race-free equations in three distinct explanatory models of dyspnea and chest CT scan abnormalities. Race-neutral/race-free reference equations may improve pulmonary disease diagnoses and treatment in populations highly vulnerable to lung disease.

Citing Articles

How do deep-learning models generalize across populations? Cross-ethnicity generalization of COPD detection.

D Almeida S, Norajitra T, Luth C, Wald T, Weru V, Nolden M Insights Imaging. 2024; 15(1):198.

PMID: 39112910 PMC: 11306482. DOI: 10.1186/s13244-024-01781-x.


Rethinking the Role of Race in Lung Function: The Shift to Race-Neutral Spirometry Interpretation.

Kanj A, Niven A, Cowl C, Yadav H Mayo Clin Proc. 2024; 99(10):1547-1552.

PMID: 39093270 PMC: 11449646. DOI: 10.1016/j.mayocp.2024.05.018.


Implications of Race Adjustment in Lung-Function Equations.

Diao J, He Y, Khazanchi R, Tiako M, Witonsky J, Pierson E N Engl J Med. 2024; 390(22):2083-2097.

PMID: 38767252 PMC: 11305821. DOI: 10.1056/NEJMsa2311809.


Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review.

Davidson S, Idris M, Awad C, Henriques King M, Westney G, Ponce M Int J Chron Obstruct Pulmon Dis. 2024; 19:969-980.

PMID: 38708410 PMC: 11067926. DOI: 10.2147/COPD.S430249.

References
1.
Zach J, Newell Jr J, Schroeder J, Murphy J, Curran-Everett D, Hoffman E . Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest Radiol. 2012; 47(10):596-602. PMC: 3703944. DOI: 10.1097/RLI.0b013e318262292e. View

2.
Lederer D, Benn E, Barr R, Wilt J, Reilly G, Sonett J . Racial differences in waiting list outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 177(4):450-4. PMC: 2258441. DOI: 10.1164/rccm.200708-1260OC. View

3.
Bailey Z, Krieger N, Agenor M, Graves J, Linos N, Bassett M . Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017; 389(10077):1453-1463. DOI: 10.1016/S0140-6736(17)30569-X. View

4.
Ekstrom M, Mannino D . Research race-specific reference values and lung function impairment, breathlessness and prognosis: Analysis of NHANES 2007-2012. Respir Res. 2022; 23(1):271. PMC: 9526909. DOI: 10.1186/s12931-022-02194-4. View

5.
Stanojevic S, Kaminsky D, Miller M, Thompson B, Aliverti A, Barjaktarevic I . ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2021; 60(1). DOI: 10.1183/13993003.01499-2021. View